Company page

Ac Immune Sa

Ac Immune SA is a public company traded under the ticker ACIU in the American market, with a market capitalization of approximately $244.26 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Ac Immune is committed to advancing its research and development efforts to address significant unmet medical needs in this field.